✦ LIBER ✦

Pharmacokinetics and metabolism of moxestrol in humans

✍ Scribed by J. Salmon; D. Coussediere; C. Cousty; J.P. Raynaud

Book ID: 116003205
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 904 KB
Volume: 18
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(83)90132-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and metabolism of codei

Pharmacokinetics and metabolism of codeine in humans

✍ Dr Tom B. Vree; Corrien P. W. G. M. Verwey-Van Wissen 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Codeine (30 mg phosphate) was metabolized by eight human volunteers to the following six metabolites: codeine-6-glucuronide 81 .O+ 9.3 per cent, norcodeine 2.16? 1.44 per cent, morphine 0-562 0-39 per cent, morphine-3-glucuronide 2-10? 1-24 per cent, morphine-6-glucuronide 0-80k 0.63 per cent, and n

Pharmacokinetics and metabolism of broti

Pharmacokinetics and metabolism of brotizolam in humans.

✍ WD Bechtel 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Pharmacokinetics, metabolism and elimina

Pharmacokinetics, metabolism and elimination of itanoxone in humans

✍ F. E. H. Crawley; R. Hyacinthe; P. Poitou; A. Donath 📂 Article 📅 1983 🏛 Springer-Verlag 🌐 English ⚖ 792 KB

Pharmacokinetics and metabolism of bisop

Pharmacokinetics and metabolism of bisoprolol enantiomers in humans

✍ Yuji Horikiri; Takehiko Suzuki; Masakazu Mizobe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Aspects of anthocyanin absorption, metab

Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans

✍ Kay, Colin D 📂 Article 📅 2006 🏛 Cambridge University Press 🌐 English ⚖ 230 KB

Pharmacokinetics and metabolism of iodo-

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

✍ K. Mross; U. Mayer; K. Hamm; K. Burk; D. K. Hossfeld 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 629 KB

The pharmacokinetics of doxorubicin (DOX), iodo-doxorubicin (I-DOX) and their metabolites in plasma has been examined in five patients each receiving 50 mg/m2 of both anthracyclines as a bolus injection. Terminal half-life, mean residence time (MRT), peak plasma concentration Cmax, and area under th